Real-world experience with intravaginal culture using INVOCELL: an alternative model for infertility treatment.

Journal: F&S reports
Published Date: Nov 20, 2020

Abstract

OBJECTIVE: To describe the current practice indications, methodology, and outcomes from a real-world experience of intravaginal culture (IVC) using INVOCELL.

Authors

  • Teru Jellerette-Nolan
    Ferring Pharmaceuticals Inc., Parsippany, New Jersey.
  • Amber R Cooper
    Vios Fertility Institute, Saint Louis, Missouri.
  • Kevin J Doody
    Center for Assisted Reproduction, Bedford, Texas.
  • John E Nichols
    Piedmont Reproductive Endocrinology Group, Greenville, South Carolina.
  • John K Park
    Carolina Conceptions, Raleigh, North Carolina.
  • Robin L Poe-Zeigler
    The New Hope Center for Reproductive Medicine, Virginia Beach, Virginia.
  • Andrew F Khair
    Ferring Pharmaceuticals Inc., Parsippany, New Jersey.
  • Laura M Stong
    Ferring Pharmaceuticals Inc., Parsippany, New Jersey.
  • Richard J Paulson
    Department of Obstetrics and Gynecology, University of Southern California, Keck School of Medicine, Los Angeles, California.
  • Gaurang S Daftary
    Ferring Pharmaceuticals Inc., Parsippany, New Jersey.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals